Healthcare and Pharma
ESG consulting for healthcare and pharmaceutical companies in India covering BRSR compliance, biomedical waste (BMW Rules) management, social impact measurement, API supplier ESG assessment, and responsible sourcing advisory. We tailor ESG advisory to the material issues, regulatory context, and value creation opportunities that matter in this sector.
5
Focus Areas
4
Regulatory Themes
3
Relevant Services
ESG material topics in Healthcare and Pharma
Based on SASB Industrials, GRI standards and our proprietary materiality database across 200+ clients.
Patient Safety and Product Responsibility
Quality systems, pharmacovigilance, product stewardship, and patient-facing clinical safety outcomes are core material topics for listed pharma and hospital groups seeking credible institutional ESG ratings.
Biomedical Waste and Environmental Compliance
Hospitals and pharma manufacturers face direct BMW Rules enforcement obligations and investor scrutiny on pharmaceutical wastewater treatment, hazardous waste handling, and utility consumption intensity.
Patient Access, Affordability, and Business Ethics
Stakeholders in India and globally expect a credible and evidenced position on medicine access, pricing practices, clinical trial ethics, and responsible marketing conduct.
API Supplier Integrity and Supply Chain Traceability
The pharmaceutical sector depends on highly regulated supply chains where quality system failures, labour issues, and sourcing transparency gaps can escalate rapidly to regulatory and reputational consequences.
What shapes ESG obligations in Healthcare and Pharma
Framework / Regulation
Type
Scope & Applicability
Effective
SEBI BRSR mandatory reporting requirements
for listed healthcare and pharmaceutical companies with principal value indicators covering environmental and social performance
Biomedical Waste Management Rules (BMW Rules)
and enforcement obligations for hospitals, nursing homes, clinics, and pharmaceutical manufacturing facilities across India
Growing stakeholder expectations
on patient access, medicine affordability, clinical trial ethics, responsible marketing, and pharmaceutical workforce safety standards
International pharmaceutical customer and institutional investor requirements
on responsible API sourcing, contract manufacturer audits, and supply chain transparency documentation
How we help Healthcare and Pharma organisations
These are the services most often used by clients in this sector, based on regulatory pressure, operating needs, and reporting maturity.
GHG Inventory & Net Zero Pathway
Pharma Scope 1/2/3 inventory, carbon intensity targets and credit strategy
BRSR & GRI Sustainability Reporting
SEBI BRSR, GRI and ISSB reporting for listed pharma and hospital groups
Ethical Supply Chain & UNGP Compliance
UNGP and value-chain human-rights risk for pharmaceutical supply chains
DEI & Patient Social Impact
Diversity, inclusion and social impact metrics including healthcare access
ESG Data & Performance Metrics
KPI framework and benchmarks for pharma ESG performance tracking
ESG Policy & Regulatory Compliance
Policy design and implementation for health-sector ESG regulations